Optogenetic probes for measuring membrane potential
US-9518103-B2 · Dec 13, 2016 · US
US9702874B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9702874-B2 |
| Application number | US-201514942992-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 16, 2015 |
| Priority date | Aug 23, 2010 |
| Publication date | Jul 11, 2017 |
| Grant date | Jul 11, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides methods for characterizing cellular physiology by incorporating into an electrically excitable cell an optical reporter of, and an optical actuator of, electrical activity. A signal is obtained from the optical reporter in response to a stimulation of the cell. Either or both of the optical reporter and actuator may be based on genetically-encoded rhodopsins incorporated into the cell. The invention provides all optical methods that may be used instead of, or as a complement to, traditional patch clamp technologies and that can provide rapid, accurate, and flexible assays of cellular physiology.
Opening claim text (preview).
What is claimed is: 1. A method for evaluating the function of a neuron, the method comprising: providing a first neuron that includes an optical reporter of electrical activity and a second neuron that is in communication with the first neuron via at least one synapse; obtaining a signal from the optical reporter in response to a stimulation of the second neuron; and evaluating the signal in order to determine a functional property of the neuron. 2. The method of claim 1 , wherein the optical reporter of electrical activity comprises a microbial rhodopsin with one or more mutations. 3. The method of claim 1 , wherein the second neuron includes an actuator of electrical activity. 4. The method of claim 3 , wherein the actuator of electrical activity is a protein. 5. The method of claim 4 , wherein the protein is a channelrhodopsin. 6. The method of claim 4 , wherein characterizing the neuron comprises evaluating a response to exposure to a compound. 7. The method of claim 4 , wherein evaluating the signal comprises using a computer system to characterize an AP waveform of the first neuron. 8. The method of claim 4 , wherein the optical reporter of electrical activity comprises a microbial rhodopsin with one or more mutations. 9. The method of claim 4 wherein the optical reporter of electrical activity is part of a fusion protein that also includes a fluorescent Ca++ indicator. 10. The method of claim 9 , wherein the fluorescent Ca++ indicator is GCaMP6f. 11. A method for evaluating the function of a cardiomyocyte, the method comprising: providing a first cardiomyocyte that includes an optical reporter of electrical activity and a second cardiomyocyte that is in communication with the first cardiomyocyte via at least one gap junction; obtaining a signal from the optical reporter in response to a stimulation of the second cardiomyocyte; and evaluating the signal in order to determine a functional property of the cardiomyocyte. 12. The method of claim 11 , wherein the optical reporter of electrical activity comprises a microbial rhodopsin with one or more mutations. 13. The method of claim 11 , wherein the second cardiomyocyte includes an actuator of electrical activity. 14. The method of claim 13 , wherein the actuator of electrical activity is a protein. 15. The method of claim 14 , wherein the protein is a channelrhodopsin. 16. The method of claim 14 , wherein characterizing the cardiomyocyte comprises evaluating a response to exposure to a compound. 17. The method of claim 14 , wherein evaluating the signal comprises using a computer system to characterize an AP waveform of the first cardiomyocyte. 18. The method of claim 14 , wherein the optical reporter of electrical activity comprises a microbial rhodopsin with one or more mutations. 19. The method of claim 14 wherein the optical reporter of electrical activity is part of a fusion protein that also includes a fluorescent Ca++ indicator. 20. The method of claim 19 , wherein the fluorescent Ca++ indicator is GCaMP6f.
using specific carrier or receptor proteins as ligand binding reagents {where possible specific carrier or receptor proteins are classified with their target compounds} · CPC title
Cells, viruses, ghosts, red blood cells, viral vectors, used for imaging or diagnosis in vivo · CPC title
Assays involving receptors, cell surface antigens or cell surface determinants · CPC title
Fluorescence in vivo · CPC title
involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.